期刊文献+

大疱性类天疱疮患者疱液中趋化因子受体5和可诱导共刺激分子的检测 被引量:3

Detection of C-X-C chemokine receptor type 5 and inducible costimulator in blister fluid of patients with bullous pemphigoid
原文传递
导出
摘要 目的检测CX—C趋化因子受体5(CXCR5)和可诱导共刺激分子(ICOS)在大疱性类天疱疮(BP)患者疱液中的水平,探讨其在BP发病机制中的意义。方法收集15例BP患者疱液为实验组,15例Ⅱ度烧伤患者疱液为对照组,采用酶联免疫吸附测定(ELISA)方法分别检测CXCR5及ICOS在两组疱液中的水平。结果实验组及对照组疱液中CXCR5水平分别为(219±145.31)、(147±23.83)ng/L,差异有统计学意义(t=4.577,P〈0.05),但疱液中ICOS水平差异无统计学意义[(30.18±14.86)比(21.43±5.32)ng/L,t=1.628,P〉0.05]。结论CXCR5的表达可能与BP发病有一定关系,而ICOS与BP发病的关系尚需进一步研究。 Objective To detect levels of C-X-C chemokine receptor type 5 (CXCR5) and inducible costimulator (ICOS) in blister fluid of patients with bullous pemphigoid (BP), and to explore their significance in the pathogenesis of BP. Methods Blister fluid samples were collected from 15 patients with BP (experimental group) and 15 patients with second-degree burns (control group). Enzymelinked immunosorbent assay (ELISA) was performed to detect the levels of CXCR5 and ICOS in the 2 groups. Results The level of CXCR5 was significantly higher in the experimental group than in the control group (219 ± 145.31 vs. 147 ± 23.83 ng/L, t = 4.577, P 〈 0.05), while no significant difference in the ICOS level was observed between the 2 groups (30.18 ± 14.86 vs. 21.43 ± 5.32 ng/L, t = 1.628, P 〉 0.05). Conclusion The expression of CXCR5 may be associated with the occurrence of BP, but further researches are needed to determine the relationship between ICOS and the occurrence of BP.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2017年第1期44-45,共2页 Chinese Journal of Dermatology
关键词 类天疱疮 大疱性 受体 CXCR5 可诱导协同刺激分子 疱液 Pemphigoid, bullous Receptors, CXCR5 Inducible costimulator Blister fluid
  • 相关文献

参考文献3

二级参考文献25

  • 1刘海娜,吴春玲,蒋莉,张晓莉,李舒帆,王晓非.系统性红斑狼疮患者血浆巨噬细胞衍生趋化因子水平及临床意义[J].中华风湿病学杂志,2005,9(3):142-144. 被引量:8
  • 2高霞,崔淑婷.32例大疱性类天疱疮治疗与随访观察[J].中国麻风皮肤病杂志,2007,23(4):360-360. 被引量:1
  • 3袁双龙,蒋莉,张晓莉,李舒帆,段宏梅,王晓非.原发性干燥综合症患者血清IL-21水平及其临床意义[J].细胞与分子免疫学杂志,2007,23(2):124-126. 被引量:19
  • 4Kakinuma T, Wakugawa M, Nakamura K et al. High level of thymus and activation-regulatedchemokine in blister fluid and sera of patients with bullous pemphigoid[J]. Br J Dermatol,2003; 148(2) :203-210.
  • 5Flier J, Boorsnm D M, Bruyrmeel D Pet al. The CXCR3 activating chemokines IP-10, Mig and IP-9 are expressed in allergic but not in irritant patch test reactions [ J ]. J Invest Dermatol, 1999 ; 113 (4) : 574-578.
  • 6Ono S J, Nakamura T, Miyazaki D et al. Chemokines: roles in leukocyte development, trafficking, and effector function[J]. J Allergy Clin Immunol, 2003 ; 111 (6) : 1185-1199.
  • 7Ruehhnmm J M, Xiang R, Niethammer A Get al. Mig/CXCL9 chemokine gene therapy combines with antibody eytokine fusion protein to suppress growth and dissemination of murine colon carcinoma[J].Cancer Research, 2001 ;61(23) :8498-8503.
  • 8Horikawa T, Nakaymna T, Hikita I et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/ CCL22 in epidermal keratinocytes and their roles in atopic dermatitis [ J ]. hat Immunol, 2002 ; 14 (7) : 767-773.
  • 9Hashimoto S, Nakamura K, Oyama N et al. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis[ J ]. J Dermatol Sci, 2006; 44(2) :93-99.
  • 10Xiao T, Fujita H, Saeki H et al. Thymus and activation-regulated chemokine(TARC/CCLl7) prcduced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN- gamma [ J ]. Cytokine, 2003 ; 23 ( 4-5 ) :126-132.

共引文献42

同被引文献32

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部